These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
440 related articles for article (PubMed ID: 20175845)
21. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. Remitz A; Harper J; Rustin M; Goldschmidt WF; Palatsi R; van der Valk PG; Sharpe G; Smith CH; Dobozy A; Turjanmaa K; Acta Derm Venereol; 2007; 87(1):54-61. PubMed ID: 17225017 [TBL] [Abstract][Full Text] [Related]
22. A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patients. Reitamo S; Rustin M; Harper J; Kalimo K; Rubins A; Cambazard F; Brenninkmeijer EE; Smith C; Berth-Jones J; Ruzicka T; Sharpe G; Taieb A; Br J Dermatol; 2008 Sep; 159(4):942-51. PubMed ID: 18637898 [TBL] [Abstract][Full Text] [Related]
23. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects. Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812 [TBL] [Abstract][Full Text] [Related]
24. Atopic dermatitis management with tacrolimus ointment (Protopic). Kapp A; Allen BR; Reitamo S J Dermatolog Treat; 2003; 14(Suppl 1):5-16. PubMed ID: 14522634 [TBL] [Abstract][Full Text] [Related]
25. Pimecrolimus cream in repigmentation of vitiligo. Seirafi H; Farnaghi F; Firooz A; Vasheghani-Farahani A; Alirezaie NS; Dowlati Y Dermatology; 2007; 214(3):253-9. PubMed ID: 17377388 [TBL] [Abstract][Full Text] [Related]
26. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study. Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990 [TBL] [Abstract][Full Text] [Related]
27. Topical pimecrolimus in the treatment of vitiligo. Boone B; Ongenae K; Van Geel N; Vernijns S; De Keyser S; Naeyaert JM Eur J Dermatol; 2007; 17(1):55-61. PubMed ID: 17324829 [TBL] [Abstract][Full Text] [Related]
28. Repigmentation of pretibial vitiligo with calcineurin inhibitors under occlusion. Hartmann A; Bröcker EB; Hamm H J Dtsch Dermatol Ges; 2008 May; 6(5):383-5. PubMed ID: 18042249 [TBL] [Abstract][Full Text] [Related]
29. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial. Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R; Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: results of a randomized, double-blind, vehicle-controlled study. Dawid M; Veensalu M; Grassberger M; Wolff K J Dtsch Dermatol Ges; 2006 Nov; 4(11):942-6. PubMed ID: 17081269 [TBL] [Abstract][Full Text] [Related]
31. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Lepe V; Moncada B; Castanedo-Cazares JP; Torres-Alvarez MB; Ortiz CA; Torres-Rubalcava AB Arch Dermatol; 2003 May; 139(5):581-5. PubMed ID: 12756094 [TBL] [Abstract][Full Text] [Related]
32. Analysis of interleukin-10 levels in lesions of vitiligo following treatment with topical tacrolimus. Taher ZA; Lauzon G; Maguiness S; Dytoc MT Br J Dermatol; 2009 Sep; 161(3):654-9. PubMed ID: 19438859 [TBL] [Abstract][Full Text] [Related]
33. Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study. Saraceno R; Nisticò SP; Capriotti E; Chimenti S Dermatol Ther; 2009; 22(4):391-4. PubMed ID: 19580584 [TBL] [Abstract][Full Text] [Related]
34. A single-center open-label long-term comparison of tacrolimus ointment and topical corticosteroids for treatment of atopic dermatitis. Neumann E; Amtage D; Bruckner-Tuderman L; Mockenhaupt M J Dtsch Dermatol Ges; 2008 Jul; 6(7):548-53. PubMed ID: 18248495 [TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis. Hanifin JM; Paller AS; Eichenfield L; Clark RA; Korman N; Weinstein G; Caro I; Jaracz E; Rico MJ; J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S186-94. PubMed ID: 16021174 [TBL] [Abstract][Full Text] [Related]
36. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study. Pacor ML; Di Lorenzo G; Martinelli N; Mansueto P; Rini GB; Corrocher R Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819 [TBL] [Abstract][Full Text] [Related]
37. Topical tacrolimus is more effective for treatment of vitiligo in patients of skin of color. Silverberg JI; Silverberg NB J Drugs Dermatol; 2011 May; 10(5):507-10. PubMed ID: 21533297 [TBL] [Abstract][Full Text] [Related]
38. Vitiligo, NB-UVB and tacrolimus: our experience in Naples. Baldo A; Lodi G; Di Caterino P; Monfrecola G G Ital Dermatol Venereol; 2014 Feb; 149(1):123-30. PubMed ID: 24566573 [TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis. Bieber T; Vick K; Fölster-Holst R; Belloni-Fortina A; Städtler G; Worm M; Arcangeli F Allergy; 2007 Feb; 62(2):184-9. PubMed ID: 17298428 [TBL] [Abstract][Full Text] [Related]
40. Topical tacrolimus in the management of atopic dermatitis in Japan. Furue M; Uchi H; Moroi Y; Ogawa S; Nakahara T; Urabe K Dermatol Ther; 2006; 19(2):118-26. PubMed ID: 16669995 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]